Healthcare provider profile · identity verified

David L Rebedew, MD

Family Practice · MONROE, WI · NPI 1184966509

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	455	110
Omeprazole	Omeprazole	193	60
Eliquis	Apixaban	165	25
Losartan Potassium	Losartan Potassium	159	45
Gabapentin	Gabapentin	152	42
Jardiance	Empagliflozin	145	24
Furosemide	Furosemide	130	30
Levothyroxine Sodium	Levothyroxine Sodium	130	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	128	20
Lisinopril	Lisinopril	125	37
Rosuvastatin Calcium	Rosuvastatin Calcium	114	26
Duloxetine Hcl	Duloxetine Hcl	107	31
Amlodipine Besylate	Amlodipine Besylate	106	34
Pantoprazole Sodium	Pantoprazole Sodium	95	25
Metformin Hcl Er	Metformin Hcl	87	26
Metoprolol Succinate	Metoprolol Succinate	86	27
Tamsulosin Hcl	Tamsulosin Hcl	85	23
Carvedilol	Carvedilol	83	22
Hydrochlorothiazide	Hydrochlorothiazide	81	26
Metformin Hcl	Metformin Hcl	79	24
Ozempic	Semaglutide	76	16
Mirtazapine	Mirtazapine	75	26
Escitalopram Oxalate	Escitalopram Oxalate	72	16
Spironolactone	Spironolactone	71	17
Sertraline Hcl	Sertraline Hcl	68	21
Mounjaro	Tirzepatide	66	17
Alendronate Sodium	Alendronate Sodium	65	19
Metoprolol Tartrate	Metoprolol Tartrate	57	17
Myrbetriq	Mirabegron	57	suppressed
Bupropion Xl	Bupropion Hcl	54	14
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	53	11
Tramadol Hcl	Tramadol Hcl	52	16
Trazodone Hcl	Trazodone Hcl	50	17
Clopidogrel	Clopidogrel Bisulfate	49	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	49	suppressed
Clonazepam	Clonazepam	48	suppressed
Famotidine	Famotidine	46	19
Baclofen	Baclofen	44	suppressed
Montelukast Sodium	Montelukast Sodium	43	suppressed
Morphine Sulfate Er	Morphine Sulfate	42	suppressed
Potassium Chloride	Potassium Chloride	42	12
Albuterol Sulfate Hfa	Albuterol Sulfate	41	17
Oxycodone Hcl	Oxycodone Hcl	41	12
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	40	suppressed
Finasteride	Finasteride	40	suppressed
Ezetimibe	Ezetimibe	39	14
Venlafaxine Hcl Er	Venlafaxine Hcl	38	12
Pregabalin	Pregabalin	37	11
Diazepam	Diazepam	35	suppressed
Glatopa	Glatiramer Acetate	35	suppressed
Meloxicam	Meloxicam	35	15
Tizanidine Hcl	Tizanidine Hcl	34	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	12
Simvastatin	Simvastatin	30	12
Alprazolam	Alprazolam	29	suppressed
Buspirone Hcl	Buspirone Hcl	28	suppressed
Ondansetron Hcl	Ondansetron Hcl	28	suppressed
Topiramate	Topiramate	28	suppressed
Allopurinol	Allopurinol	27	suppressed
Aripiprazole	Aripiprazole	27	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Fluticasone Propionate	Fluticasone Propionate	25	14
Lamotrigine	Lamotrigine	25	suppressed
Lorazepam	Lorazepam	25	suppressed
Risperidone	Risperidone	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Linzess	Linaclotide	24	suppressed
Methenamine Hippurate	Methenamine Hippurate	24	suppressed
Fentanyl	Fentanyl	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Colestipol Hcl	Colestipol Hcl	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Latanoprost	Latanoprost	18	suppressed
Glipizide	Glipizide	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Prednisone	Prednisone	17	11
Trimethoprim	Trimethoprim	17	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	12
Hydroxyzine Hcl	Hydroxyzine Hcl	16	11
Methylphenidate Hcl	Methylphenidate Hcl	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Cilostazol	Cilostazol	15	suppressed
Desmopressin Acetate	Desmopressin Acetate	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Atenolol	Atenolol	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Ethosuximide	Ethosuximide	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Betaxolol Hcl	Betaxolol Hcl	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Brilinta	Ticagrelor	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Eplerenone	Eplerenone	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Suboxone	Buprenorphine Hcl/Naloxone Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error